Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer
The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ...
Armed robbery in Revesby10h
Breakthrough IBD Treatment Heads Into Clinical Trials
People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most ...
Armed robbery in Revesby17h
Parkinson's Course Breakthrough Transforms Lives
University of Tasmania and Parkinson's Research Foundation bridge gap in Parkinson's knowledge with first of its kind resourceFree online course ...
Rolling Out23h
This medical breakthrough could change sickle cell forever
New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.